The tweet was deleted by the author.
But we saved everything 🙂.
NovoCure Ltd has announced topline results from its Phase 3 TRIDENT clinical trial.
The company shared the preliminary data in a press release, signaling progress in its research pipeline. Further details about the clinical outcomes and potential impact are expected as more comprehensive analysis becomes available.